Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers

Endocrine Reviews

Volumn 27, Issue 5, 2006, Pages 468-484

  Cools, Martine ^a,b   Drop, Stenvert L S ^b   Wolffenbuttel, Katja P ^b   Oosterhuis, J Wolter ^a   Looijenga, Leendert H J ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDIN; OCTAMER TRANSCRIPTION FACTOR 4;

CELL MATURATION; CELL MIGRATION; FOLLOW UP; GENOME IMPRINTING; GENOTYPE; GERM CELL; GERM CELL TUMOR; GONAD; GONADAL DYSGENESIS; GONADOBLASTOMA; HERMAPHRODITISM; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPE; MOLECULAR GENETICS; NEOPLASM; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEXUAL DEVELOPMENT; TESTOSTERONE SYNTHESIS; VIRILIZATION; Y CHROMOSOME;

BIOLOGICAL MARKERS; CROSS-SECTIONAL STUDIES; GENOTYPE; GERM CELLS; HERMAPHRODITISM; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS, GERM CELL AND EMBRYONAL; RISK FACTORS; SEX DIFFERENTIATION DISORDERS;

EID: 33747037485     PISSN: 0163769X     EISSN: 0163769X     Source Type: Journal    
DOI: 10.1210/er.2006-0005     Document Type: Review

References (124)

1. Houk CP, Lee PA 2005 Intersexed states: diagnosis and management. Endocrinol Metab Clin North Am 34:791- 810, xi
2. Grumbach MM, Hughes IA, Conte FA 2003 Disorders of sex differentiation. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KM, eds. Williams textbook of endocrinology. 10th ed. Philadelphia: W.B. Saunders (Elsevier); 842-1002
3. Money J, Ehrhardt AA 1972 Man and woman, boy and girl. Baltimore: Johns Hopkins University Press
4. Reiner WG, Gearhart JP 2004 Discordant sexual identity in some genetic males with cloacal exstrophy assigned to female sex at birth. N Engl J Med 350:333-341
5. Reiner WG 1999 Assignment of sex in neonates with ambiguous genitalia. Curr Opin Pediatr 11:363-365
6. Creighton SM, Minto CL, Liao LM, Alderson J, Simmonds M 2004 Meeting between experts: evaluation of the first UK forum for lay and professional experts in intersex. Patient Educ Couns 54:153-157
7. Crone J, Amann G, Gheradini R, Kirchlechner V, Fekete CN 2002 Management of 46, XY partial gonadal dysgenesis-revisited. Wien Klin Wochenschr 114:462-467
8. Official web site of the Intersex Society of North America. http://www.isna.org
9. Creighton S, Minto C 2001 Managing intersex. BMJ 323:1264-1265
10. Wilson JD 1999 The role of androgens in male gender role behavior. Endocr Rev 20:726-737
11. Reiner WG, Kropp BP 2004 A 7-year experience of genetic males with severe phallic inadequacy assigned female. J Urol 172:2395-2398
12. Slijper FM, Drop SL, Molenaar JC, de Muinck Keizer-Schrama SM 1998 Long-term psychological evaluation of intersex children. Arch Sex Behav 27:125-144
13. Meyer-Bahlburg HF 1999 Gender assignment and reassignment in 46,XY pseudohermaphroditism and related conditions. J Clin Endocrinol Metab 84:3455-3458
14. Nihoul-Fekete C, Thibaud E, Lortat-Jacob S, Josso N 2006 Longterm surgical results and patient satisfaction with male pseudohermaphroditism or true hermaphroditism: a cohort of 63 patients. J Urol 175:1878-1884
15. Nihoul-Fekete C 2005 Does surgical genitoplasty affect gender identity in the intersex infant? Horm Res 64(Suppl 2):23-26
16. Scully RE 1970 Gonadoblastoma. A review of 74 cases. Cancer 25:1340-1356
17. Verp MS, Simpson JL 1987 Abnormal sexual differentiation and neoplasia. Cancer Genet Cytogenet 25:191-218
18. Schellhas HF 1974 Malignant potential of the dysgenetic gonad. Part 1. Obstet Gynecol 44:289-309
19. Manuel M, Katayama PK, Jones Jr HW 1976 The age of occurrence of gonadal tumors in intersex patients with a Y chromosome. Am J Obstet Gynecol 124:293-300
20. Robboy SJ, Miller T, Donahoe PK, Jahre C, Welch WR, Haseltine FP, Miller WA, Atkins L, Crawford JD 1982 Dysgenesis of testicular and streak gonads in the syndrome of mixed gonadal dysgenesis: perspective derived from a clinicopathologic analysis of twenty-one cases. Hum Pathol 13:700-716
21. Troche V, Hernandez E 1986 Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv 41:74-79
22. Savage MO, Lowe DG 1990 Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol (Oxf) 32:519-533
23. Oosterhuis JW, Looijenga LH 2005 Testicular germ-cell tumours in a broader perspective. Nat Rev Cancer 5:210-222
24. Gourlay WA, Johnson HW, Pantzar JT, McGillivray B, Crawford R, Nielsen WR 1994 Gonadal tumors in disorders of sexual differentiation. Urology 43:537-540
25. Morris JM, Mahesh VB 1963 Further observations on the syndrome, "Testicular Feminization". Am J Obstet Gynecol 87:731-748
26. Bangsboll S, Qvist I, Lebech PE, Lewinsky M 1992 Testicular feminization syndrome and associated gonadal tumors in Denmark. Acta Obstet Gynecol Scand 71:63-66
27. Regadera J, Martinez-Garcia F, Paniagua R, Nistal M 1999 Androgen insensitivity syndrome: an immunohistochemical, ultrastructural, and morphometric study. Arch Pathol Lab Med 123:225-234
28. Cools M, van Aerde K, Kersemaekers AMF, Boter M, Drop SL, Wolffenbuttel KP, Steyerberg EW, Oosterhuis JW, Looijenga LH 2005 Morphological and immunohistochemical differences between gonadal maturation delay and early germ cell neoplasia in patients with undervirilization syndromes. J Clin Endocrinol Metab 90:5295-5303
29. van Niekerk WA, Retief AE 1981 The gonads of human true hermaphrodites. Hum Genet 58:117-122
30. Ulbright TM 1997 Neoplasms of the testis. In: Bostwick DG, Eble JN, eds. Urologic surgical pathology. 1st ed. St. Louis, MO: Mosby
31. Rajpert-De Meyts E, Hanstein R, Jorgensen N, Graem N, Vogt PH, Skakkebaek NE 2004 Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod 19:1338-1344
32. Gobel U, Schneider DT, Calaminus G, Haas RJ, Schmidt P, Harms D 2000 Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann Oncol 11:263-271
33. Hussain A 2005 Germ cell tumors. Curr Opin Oncol 17:268-274
34. Gornall P 1997 Paediatric surgical oncology. 7-germ cell tumours. Eur J Surg Oncol 23:68-72
35. Lau Y, Chou P, Iezzoni J, Alonzo J, Komuves L 2000 Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 91:160-164
36. Lau YF 1999 Gonadoblastoma, testicular and prostate cancers, and the TSPY gene. Am J Hum Genet 64:921-927
37. Salo P, Kaariainen H, Petrovic V, Peltomaki P, Page DC, de la Chapelle A 1995 Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 14:210-214
38. Tsuchiya K, Reijo R, Page DC, Disteche CM 1995 Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 57:1400-1407
39. Page DC 1987 Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101(Suppl):151-155
40. Pinczowski D, McLaughlin JK, Lackgren G, Adami HO, Persson I 1991 Occurrence of testicular cancer in patients operated on for cryptorchidism and inguinal hernia. J Urol 146:1291-1294
41. Looijenga LH, Oosterhuis JW 2002 Pathobiology of testicular germ cell tumors: views and news. Anal Quant Cytol Histol 24:263-279
42. Rutgers JL, Scully RE 1987 Pathology of the testis in intersex syndromes. Semin Diagn Pathol 4:275-291
43. Rutgers JL, Scully RE 1991 The androgen insensitivity syndrome (testicular feminization): a clinicopathologic study of 43 cases. Int J Gynecol Pathol 10:126-144
44. Ramani P, Yeung CK, Habeebu SS 1993 Testicular intratubular germ cell neoplasia in children and adolescents with intersex. Am J Surg Pathol 17:1124-1133
45. Salle B, Hedinger C 1970 Gonadal histology in children with male pseudohermaphroditism and mixed gonadal dysgenesis. Acta Endocrinol (Copenh) 64:211-227
46. Beheshti M, Hardy BE, Mancer K, McLorie G, Churchill BM 1987 Neoplastic potential in patients with disorders of sexual differentiation. Urology 29:404-407
47. Armstrong GR, Buckley CH, Kelsey AM 1991 Germ cell expression of placental alkaline phosphatase in male pseudohermaphroditism. Histopathology 18:541-547
48. Muller J 1984 Morphometry and histology of gonads from twelve children and adolescents with the androgen insensitivity (testicular feminization) syndrome. J Clin Endocrinol Metab 59:785-789
49. Cassio A, Cacciari E, D'Errico A, Balsamo A, Grigioni FW, Pascucci MG, Bacci F, Tacconi M, Mancini AM 1990 Incidence of intratubular germ cell neoplasia in androgen insensitivity syndrome. Acta Endocrinol (Copenh) 123:416-422
50. Ahmed SF, Cheng A, Dovey L, Hawkins JR, Martin H, Rowland J, Shimura N, Tait AD, Hughes IA 2000 Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 85:658-665
51. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K 1997 Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr 156:7-14
52. McPhaul MJ, Marcelli M, Zoppi S, Griffin JE, Wilson JD 1993 Genetic basis of endocrine disease. 4. The spectrum of mutations in the androgen receptor gene that causes androgen resistance. J Clin Endocrinol Metab 76:17-23
53. Boehmer AL, Brinkmann O, Bruggenwirth H, van Assendelft C, Otten BJ, Verleun-Mooijman MC, Niermeijer MF, Brunner HG, Rouwe CW, Waelkens JJ, Oostdijk W, Kleijer WJ, van der Kwast TH, de Vroede MA, Drop SL 2001 Genotype versus phenotype in families with androgen insensitivity syndrome. J Clin Endocrinol Metab 86:4151-4160
54. Quigley CA, De Bellis A, Marschke KB, el-Awady MK, Wilson EM, French FS 1995 Androgen receptor defects: historical, clinical, and molecular perspectives. Endocr Rev 16:271-321
55. Chen CP, Chern SR, Wang TY, Wang W, Wang KL, Jeng CJ 1999 Androgen receptor gene mutations in 46,XY females with germ cell tumours. Hum Reprod 14:664-670
56. Giwercman A, Muller J, Skakkebaek NE 1991 Prevalence of carcinoma in situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145:77-80
57. Muller J, Skakkebaek NE 1984 Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome. Br Med J (Clin Res Ed) 288:1419-1420
58. MacLaughlin DT, Donahoe PK 2004 Sex determination and differentiation. N Engl J Med 350:367-378
59. Fleming A, Vilain E 2005 The endless quest for sex determination genes. Clin Genet 67:15-25
60. Veitia RA, Salas-Cortes L, Ottolenghi C, Pailhoux E, Cotinot C, Fellous M 2001 Testis determination in mammals: more questions than answers. Mol Cell Endocrinol 179:3-16
61. Ahmed SF, Hughes IA 2002 The genetics of male undermasculinization. Clin Endocrinol (Oxf) 56:1-18
62. Cools M, Stoop H, Kersemaekers AMF, Drop SLS, Wolffenbuttel KP, Bourguignon J-P, Slowikowska-Hilczer J, Kula K, Faratz S, Oosterhuis JW, Looijenga LHJ 2006 Gonadoblastoma arising in undifferentiated gonadal tissue within dysgenetic gonads. J Clin Endocrinol Metab 91:2404-2413
63. Trobs RB, Hoepffner W, Buhligen U, Limbach A, Keller E, Schutz A, Horn LC, Kiess W, Bennek J 2004 Video-assisted gonadectomy in children with Ullrich Turner syndrome or 46,XY gonadal dysgenesis. Eur J Pediatr Surg 14:179-184
64. Slowikowska-Hilczer J, Szarras-Czapnik M, Kula K 2001 Testicular pathology in 46,XY dysgenetic male pseudohermaphroditism: an approach to pathogenesis of testis cancer. J Androl 22:781-792
65. Donahoe PK, Crawford JD, Hendren WH 1979 Mixed gonadal dysgenesis, pathogenesis, and management. J Pediatr Surg 14:287-300
66. Slowikowska-Hilczer J, Romer TE, Kula K 2003 Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl 24:270-278
67. Krasna IH, Lee ML, Smilow P, Sciorra L, Eierman L 1992 Risk of malignancy in bilateral streak gonads: the role of the Y chromosome. J Pediatr Surg 27:1376-1380
68. Horn LC, Limbach A, Hoepffner W, Trobs RB, Keller E, Froster UG, Richter CE, Jakubiczka S 2005 Histologic analysis of gonadal tissue in patients with Ullrich-Turner syndrome and derivative Y chromosomes. Pediatr Dev Pathol 8:197-203
69. Muller J, Skakkebaek NE, Ritzen M, Ploen L, Petersen KE 1985 Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 106:431-436
70. Medlej R, Lobaccaro JM, Berta P, Belon C, Leheup B, Toublanc JE, Weill J, Chevalier C, Dumas R, Sultan C 1992 Screening for Y-derived sex determining gene SRY in 40 patients with Turner syndrome. J Clin Endocrinol Metab 75:1289-1292
71. Kocova M, Siegel SF, Wenger SL, Lee PA, Trucco M 1993 Detection of Y chromosome sequences in Turner's syndrome by Southern blot analysis of amplified DNA. Lancet 342:140-143
72. Coto E, Toral JF, Menendez MJ, Hernando I, Plasencia A, Benavides A, Lopez-Larrea C 1995 PCR-based study of the presence of Y-chromosome sequences in patients with Ullrich-Turner syndrome. Am J Med Genet 57:393-396
73. Binder G, Koch A, Wajs E, Ranke MB 1995 Nested polymerase chain reaction study of 53 cases with Turner's syndrome: is cytogenetically undetected Y mosaicism common? J Clin Endocrinol Metab 80:3532-3536
74. Lopez M, Canto P, Aguinaga M, Torres L, Cervantes A, Alfaro G, Mendez JP, Kofman-Alfaro S 1998 Frequency of Y chromosomal material in Mexican patients with Ullrich-Turner syndrome. Am J Med Genet 76:120-124
75. Osipova GR, Karmanov ME, Kozlova SI, Evgrafov OV 1998 PCR detection of Y-specific sequences in patients with Ullrich-Turner syndrome: clinical implications and limitations. Am J Med Genet 76:283-287
76. Mendes JR, Strufaldi MW, Delcelo R, Moises RC, Vieira JG, Kasamatsu TS, Galera MF, Andrade JA, Verreschi IT 1999 Y-chromosome identification by PCR and gonadal histopathology in Turner's syndrome without overt Y-mosaicism. Clin Endocrinol (Oxf) 50:19-26
77. Gravholt CH, Fedder J, Naeraa RW, Muller J 2000 Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population study. J Clin Endocrinol Metab 85:3199-3202
78. Fernandez-Garcia R, Garcia-Doval S, Costoya S, Pasaro E 2000 Analysis of sex chromosome aneuploidy in 41 patients with Turner syndrome: a study of 'hidden' mosaicism. Clin Genet 58:201-208
79. Nishi MY, Domenice S, Medeiros MA, Mendonca BB, Billerbeck AE 2002 Detection of Y-specific sequences in 122 patients with Turner syndrome: nested PCR is not a reliable method. Am J Med Genet 107:299-305
80. Alvarez-Nava F, Soto M, Sanchez MA, Fernandez E, Lanes R 2003 Molecular analysis in Turner syndrome. J Pediatr 142:336-340
81. Joki-Erkkila MM, Karikoski R, Rantala I, Lenko HL, Visakorpi T, Heinonen PK 2002 Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome. J Pediatr Adolesc Gynecol 15:145-149
82. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D 1991 Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67:437-447
83. Pena-Alonso R, Nieto K, Alvarez R, Palma I, Najera N, Erana L, Dorantes LM, Kofman-Alfaro S, Queipo G 2005 Distribution of Y-chromosome-bearing cells in gonadoblastoma and dysgenetic testis in 45,X/46,XY infants. Mod Pathol 18:439-445
84. de Jong J, Stoop H, Dohle GR, Bangma CH, Kliffen M, van Esser JW, van den Bent M, Kros JM, Oosterhuis JW, Looijenga LH 2005 Diagnostic value of OCT3/4 for pre-invasive and invasive testicular germ cell tumours. J Pathol 206:242-249
85. Kersemaekers AM, Honecker F, Stoop H, Cools M, Molier M, Wolffenbuttel K, Bokemeyer C, Li Y, Lau YF, Oosterhuis JW, Looijenga LH 2005 Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 36:512-521
86. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW 2003 POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244-2250
87. Gidekel S, Pizov G, Bergman Y, Pikarsky E 2003 Oct-3/4 is a dose-dependent oncogenic fate determinant. Cancer Cell 4:361-370
88. Jones TD, Ulbright TM, Eble JN, Cheng L 2004 OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10:8544-8547
89. Jones TD, Ulbright TM, Eble JN, Baldridge LA, Cheng L 2004 OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 28:935-940
90. Cheng L, Thomas A, Roth LM, Zheng W, Michael H, Karim FW 2004 OCT4: a novel biomarker for dysgerminoma of the ovary. Am J Surg Pathol 28:1341-1346
91. Cheng L 2004 Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 101:2006-2010
92. Ezeh UI, Turek PJ, Reijo RA, Clark AT 2005 Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104:2255-2265
93. Hoei-Hansen CE, Nielsen JE, Almstrup K, Sonne SB, Graem N, Skakkebaek NE, Leffers H, Rajpert-De Meyts E 2004 Transcription factor AP-2γ is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10:8521-8530
94. Pesce M, Wang X, Wolgemuth DJ, Scholer H 1998 Differential expression of the Oct-4 transcription factor during mouse germ cell differentiation. Mech Dev 71:89-98
95. Niwa H, Miyazaki J, Smith AG 2000 Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376
96. Matin MM, Walsh JR, Gokhale PJ, Draper JS, Bahrami AR, Morton I, Moore HD, Andrews PW 2004 Specific knockdown of Oct4 and β2-microglobulin expression by RNA interference in human embryonic stem cells and embryonic carcinoma cells. Stem Cells 22:659-668
97. Kehler J, Tolkunova E, Koschorz B, Pesce M, Gentile L, Boiani M, Lomeli H, Nagy A, McLaughlin KJ, Scholer HR, Tomilin A 2004 Oct4 is required for primordial germ cell survival. EMBO Rep 5:1078-1083
98. Stoop H, Honecker F, Cools M, de Krijger R, Bokemeyer C, Looijenga LH 2005 Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod 20:1466-1476
99. Honecker F, Stoop H, de Krijger RR, Chris Lau YF, Bokemeyer C, Looijenga LH 2004 Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 203:849-857
100. Cools M, Honecker F, Stoop H, Veltman JD, de Krijger RR, Steyerberg E, Wolffenbuttel KP, Bokemeyer C, Lau YF, Drop SL, Looijenga LH 2006 Maturation delay of germ cells in trisomy 21 fetuses results in increased risk for the development of testicular germ cell tumors. Hum Pathol 37:101-111
101. Schnieders F, Dork T, Arnemann J, Vogel T, Werner M, Schmidtke J 1996 Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 5:1801-1807
102. Lau YF, Lau HW, Komuves LG 2003 Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 101:250-260
103. Yin YH, Li YY, Qiao H, Wang HC, Yang XA, Zhang HG, Pang XW, Zhang Y, Chen WF 2005 TSPY is a cancer testis antigen expressed in human hepatocellular carcinoma. Br J Cancer 93:458-463
104. Skakkebaek NE, Rajpert-De Meyts E, Main KM 2001 Testicular dysgenesis syndrome: an increasingly common developmental disorder with environmental aspects. Hum Reprod 16:972-978
105. Skakkebaek NE 2004 Testicular dysgenesis syndrome: new epidemiological evidence. Int J Androl 27:189-191
106. Jacobsen GK, Henriques UV 1992 A fetal testis with intratubular germ cell neoplasia (ITGCN). Mod Pathol 5:547-549
107. Hannema S, Scott I, Rajpert-De Meyts E, Skakkebaek N, Coleman N, Hughes I 2006 Testicular development in the complete androgen insensitivity syndrome. J Pathol 208:518-527
108. Sell S, Pierce GB 1994 Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest 70:6-22
109. Holm TM, Jackson-Grusby L, Brambrink T, Yamada Y, Rideout 3rd WM, Jaenisch R 2005 Global loss of imprinting leads to widespread tumorigenesis in adult mice. Cancer Cell 8:275-285
110. van Gurp RJ, Oosterhuis JW, Kalscheuer V, Mariman EC, Looijenga LH 1994 Biallelic expression of the H19 and IGF2 genes in human testicular germ cell tumors. J Natl Cancer Inst 86:1070-1075
111. Gondos B 1985 Development of the reproductive organs. Ann Clin Lab Sci 15:363-373
112. McLaren A, Southee D 1997 Entry of mouse embryonic germ cells into meiosis. Dev Biol 187:107-113
113. McLaren A 2000 Germ and somatic cell lineages in the developing gonad. Mol Cell Endocrinol 163:3-9
114. McLaren A 2003 Primordial germ cells in the mouse. Dev Biol 262:1-15
115. Pauls K, Franke FE, Buttner R, Zhou H 2005 Gonadoblastoma: evidence for a stepwise progression to dysgerminoma in a dysgenetic ovary. Virchows Arch 447:603-609
116. Hughes IA, Houk C, Ahmed SF, Lee PA; LWPES Consensus Group; ESPE Consensus Group 2006 Consensus statement on management of intersex disorders. Arch Dis Child 91:554-563
117. Hannema SE, Scott IS, Hodapp J, Martin H, Coleman N, Schwabe JW, Hughes IA 2004 Residual activity of mutant androgen receptors explains wolffian duct development in the complete androgen insensitivity syndrome. J Clin Endocrinol Metab 89:5815-5822
118. Rorth M, Rajpert-De Meyts E, Andersson L, Dieckmann KP, Fossa SD, Grigor KM, Hendry WF, Herr HW, Looijenga LH, Oosterhuis JW, Skakkebaek NE 2000 Carcinoma in situ in the testis. Scand J Urol Nephrol Suppl:166-186
119. Queipo G, Zenteno JC, Pena R, Nieto K, Radillo A, Dorantes LM, Erana L, Lieberman E, Soderlund D, Jimenez AL, Ramon G, Kofman-Alfaro S 2002 Molecular analysis in true hermaphroditism: demonstration of low-level hidden mosaicism for Y-derived sequences in 46,XX cases. Hum Genet 111:278-283
120. Hart AH, Hartley L, Parker K, Ibrahim M, Looijenga LH, Pauchnik M, Chow CW, Robb L 2005 The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104:2092-2098
121. Hustin J, Collette J, Franchimont P 1987 Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours. Int J Androl 10:29-35
122. Strohmeyer T, Reese D, Press M, Ackermann R, Hartmann M, Slamon D 1995 Expression of the c-kit proto-oncogene and its ligand stem cell factor (SCF) in normal and malignant human testicular tissue. J Urol 153:511-515
123. Rajpert-De Meyts E, Skakkebaek NE 1994 Expression of the c-kit protein product in carcinoma-in-situ and invasive testicular germ cell tumours. Int J Androl 17:85-92
124. Castrillon DH, Quade BJ, Wang TY, Quigley C, Crum CP 2000 The human VASA gene is specifically expressed in the germ cell lineage. Proc Natl Acad Sci USA 97:9585-9590